Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Patent
1998-01-09
1999-12-28
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
514736, A61K 3105
Patent
active
060082607
ABSTRACT:
A composition and method of cancer chemoprevention is disclosed. The composition and method utilize resveratrol as a cancer chemopreventative agent in mammals, including humans.
REFERENCES:
patent: 5411986 (1995-05-01), Cho et al.
patent: 5747536 (1998-05-01), Cavazza
Sanders et al., Book of Bbstracts, 214th ACS National Meeting, Am. Chem. S., Sep. 7, 1997.
Miura et al., Igaku no Ayumi, 183(8), 530-536 Abstract Only, 1997.
Jang et al., Science, 275(5297), 218-220 Abstract Only, 1997.
J.R. Landolph, "Chemical transformation in C3H 10T1/2 C18 mouse embryo fibroblasts: historical background, assessment of the transformation assay, and evolution and optimization of the transformation assay protocol," pp. 185-199, in "Transformation Assay of Established Cell Lines," T. Kakunaga et al., eds., Oxford Univ. Press, Toronto (1985).
R.J. Kulmacz et al., "Cyclo-oxygenase: measurement, purification and properties," pp. 209-277, in "Prostaglandins and Related Substances" (IRL Press, Oxford), (1987).
C.A. Reznikoff et al., "Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division," Cancer Res., 33, 3239-3249, Dec. 1973.
O.J. Plescia et al., "Subversion of immune system by tumor cells and role of prostaglandins," Proc. Nat. Acad. Sci., USA, vol. 72, No. 5, pp. 1848-1851, May, 1975.
S. Mondal et al., "Two-stage chemical oncogenesis in cultures of C3H/10T1/2 cells," Cancer Res., 36, 2254-2260, Jul. 1976.
J.S. Bertram, "Reduction in the formation of carcinogen-induced transformed foci by penicillin G sodium in the C3H/10T.sub.1/2 CL8 cell line," Cancer Lett., 7, 289-298 1979.
M.B. Sporn et al., "Chemoprevention of cancer with retinoids," Federation Proceedings, vol. 38, No. 11, 2528-2534, Oct. 1979.
F.J.G. van der Ouderaa et al., "Purification of PGH synthase from sheep vesicular glands," Methods Enzymol., 86, 60-68, 1982.
T.V. Zenser et al., "Prostaglandin H synthase-catalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical carcinogenesis," J. Pharmcol. Exp. Ther., vol. 227, No. 3, 545-550, 1983.
J.S. Goodwin, "Immunologic effects of nonsteroidal anti-inflammatory drugs," Am. J. Med., 77, 7-15, 1984.
D. Wild et al., "Prostaglandin H synthase-dependent mutagenic activation of heterocyclic aromatic amines of the IQ-type," Carcinogenesis, vol. 8, No. 4 541-545, 1987.
H.J. Prochaska et al., "Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for aniticarcinogenic enzyme inducers," Anal. Biochem., 169, 328-336, 1998.
R.C. Moon et al., "Retinoid inhibition of experimental carcinogenesis," Chemistry and Biology of Retinoids, M.I. Dawson et al., eds., CRC Press, Boca Raton, FL, 501-518, 1990.
E. Mannilla et al., "Anti-leukaemic compounds derived from stilbenes in Picea abies bark," Phytochemistry, 33, 813-816, 1993.
G.S. Jayatilake et al., "Kinase inhibitors from polygonum cuspidatum," J. Nat. Prod., vol. 56, No. 10. 1805-1810, Oct. 1993.
L.W. Wattenberg, "Prevention-therapy-basic science and the resolution of the cancer problem: presidential address," Cancer Research, 53, 5890-5896, Dec., 1993.
K. Slowing et al., "Anti-inflammatory activity of leaf extracts of Eugenia jambos in rats," J. of Ethnopharmacol., 43, 9-11, 1994.
L.A. Shamon et al., "A correlative approach for the identification of antimutagens that demonstrate chemopreventive activity," Anticancer Res., 14, 1775-1778, 1994.
Y. Zhang et al., "Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates," Proc. Natl. Acad. Sci., USA, vol. 91, 3147-3150, Apr., 1994.
S. Sharma et al., "Screening of potential chemopreventive agents using biochemical markers of carcinogenesis," Cancer Res., 54, 5848-5855, Nov. 1994.
N. Suh et al., "Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model," Anticancer Res., 15, 233-240, 1995.
C. Gerhauser et al., "Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase," Nature Med., vol. 1, No. 3, 260-266, Mar. 1995.
Jang Mei-Shiang
Moon Richard C.
Pezzuto John M.
Goldberg Jerome D.
Pharmascience
LandOfFree
Cancer chemopreventative composition and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer chemopreventative composition and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer chemopreventative composition and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2382800